Leadership

NextPhase’s executive team is composed of highly skilled professionals with previous experience in relevant fields such as biology, pharma, medicine, venture capital and management. Our research team is based in Europe. Aside from the executive team, the company has access to a wide network of world-class advisors in dermatology and immunology, as well as experts in the drug development and regulatory fields. They are actively engaged in our ongoing work.

Team

Rajeev Singh-Molares

CEO and Co-Founder

Rajeev Singh-Molares

CEO and Co-Founder

Founder and managing partner of a venture fund with an excess of 100 millions in AUM. Former EVP and president of Alcatel-Lucent

Rafael González, MD

Chief Medical Officer and Co-Founder

Rafael González, MD

Chief Medical Officer and Co-Founder

More than 10 years of experience as medical director at Health Research Associates. Consultant for several Pharma Start-ups.

Luis Mariñas, PhD

Head of Research

Luis Mariñas, PhD

Head of Research

Researcher in more than 17 projects. 4 PCT patents and more than 20 papers in peer review journals. One approved drug based on MSC.

Manuel Hermida, PhD

Chief Science Officer

Manuel Hermida, PhD

Chief Science Officer

Scientific Researcher at UDC. Several PCT patents and more than 40 papers in peer review journals. One approved drug based on MSC.

Advisors

Erik D. Laursen

Scientific advisor

Erik D. Laursen

Scientific advisor

More than twenty years of drug development experience in pharma and biotechnology companies in the U.S. and Europe.

Kenneth Draper, PhD

Pre-clinical stage advisor

Kenneth Draper, PhD

Pre-clinical stage advisor

Preclinical Discovery and Development Consultant with expertise in novel immunotherapies. Over 30 years of pharmaceutical discovery research

Mila P. Gaddy, PhD

Immunology and IP advisor

Mila P. Gaddy, PhD

Immunology and IP advisor

Managing partner at CatalytIQ, with over 7 years of experience providing clients with high impact solutions in fields including immunology

Philip Askenase, MD

MD Immunology expert

Philip Askenase, MD

MD Immunology expert

Professor of Immunology at Yale University. Working in T-Cell Mediated Suppression via miRNA in Nanovesicle Exosomes Acting Between Cells.

Todd Schlesinger, MD

Dermatology expert

Todd Schlesinger, MD

Dermatology expert

Founder and Director, Dermatology and Laser Center of Charleston, Clinical Research Center of the Carolinas. Affiliate Assistant Professor

Thanh Nga Tran, MD

Dermatology expert

Thanh Nga Tran, MD

Dermatology expert

Instructor in Dermatology at Harvard Medical School.Researcher at the Wellman Center for Photomedicine at the Massachusetts General Hospital

Pablo Lapuerta, MD

Scientific advisor

Pablo Lapuerta, MD

Scientific advisor

Over 20 years of experience in the biotech and pharmaceutical industry. 9 years at Lexicon Pharmaceutical, working in drug development.

Peter Berglund, PhD

Immunology expert

Peter Berglund, PhD

Immunology expert

Molecular biologist, immunologist and virologist with 20 years of experience in molecular virology.

Carlos Paya, MD

Industry expert

Carlos Paya, MD

Industry expert

Board member of two publicly listed companies (NYSE and NASDAQ). President and CEO, Immune Design Corp, until its acquisition by Merck.